COSMOS PHARMACEUTICAL CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,990 JPY | -2.04% |
|
-7.94% | -20.23% |
| Apr. 12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
| Jan. 12 | Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores | MT |
Evolution of the average Target Price on COSMOS Pharmaceutical Corporation
Price target over the last 5 years
History of analyst recommendation changes
56a27b.xQiPVSvSv3b5dQMZrSvHKThhdFotfqkW4MWZsa1bVTw.tl24Y2-m_DrMGGV76lKqS0k2LmpmRp5FrK2giO9jZmSaOckDEoDcHo0_bA~894bb85671519c93b26532bef7e7b36c
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
13,260
JPY
Average target price
16,603
JPY
Spread / Average Target
+25.21%
High Price Target
20,000
JPY
Spread / Highest target
+50.83%
Low Price Target
13,100
JPY
Spread / Lowest Target
-1.21%
Consensus detail
Consensus revision (last 18 months)
Analysts covering COSMOS Pharmaceutical Corporation
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 3349 Stock
- Consensus COSMOS Pharmaceutical Corporation
